2024-03-28T10:58:14Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_EEA4E92F1C87
2024-03-23T03:10:41Z
serval:BIB_EEA4E92F1C87
Emerging therapies for gout.
10.1016/j.rdc.2014.01.013
24703353
000335421300015
Edwards
N.L.
author
So
A.
author
article
review
2014
Rheumatic Diseases Clinics of North America
1558-3163
0889-857X
journal
40
2
375-387
Acetamides/therapeutic use
Adrenocorticotropic Hormone/therapeutic use
Antibodies, Monoclonal/therapeutic use
Antirheumatic Agents/therapeutic use
Benzodiazepines/therapeutic use
Gout/drug therapy
Gout Suppressants/therapeutic use
Humans
Imino Furanoses/therapeutic use
Interleukin 1 Receptor Antagonist Protein/therapeutic use
Interleukin-1beta/antagonists & inhibitors
Melanocortins/therapeutic use
Phenylacetates/therapeutic use
Polyethylene Glycols
Pyrimidinones/therapeutic use
Recombinant Fusion Proteins/therapeutic use
Thiazoles
Thioglycolates/therapeutic use
Triazoles/therapeutic use
Urate Oxidase
Uricosuric Agents/therapeutic use
eng
60_published
peer-reviewed
Publication types: Journal Article ; Review Publication Status: ppublish